Pacer Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,657
Closed -$197K 3534
2023
Q3
$197K Sell
1,657
-3,013
-65% -$450K ﹤0.01% 1539
2023
Q2
$832K Buy
+4,670
New +$857K ﹤0.01% 1221
2023
Q1
Sell
-3,840
Closed -$605K 2285
2022
Q4
$605K Buy
+3,840
New +$584K ﹤0.01% 1111
2022
Q1
Sell
-2,052
Closed -$487K 2408
2021
Q4
$487K Buy
2,052
+24
+1% +$5.61K 0.01% 1591
2021
Q3
$473K Sell
2,028
-48
-2% -$10.1K 0.01% 1157
2021
Q2
$427K Sell
2,076
-24
-1% -$4.94K 0.01% 1183
2021
Q1
$431K Sell
2,100
-42
-2% -$8.87K 0.01% 1113
2020
Q4
$459K Sell
2,142
-2,494
-54% -$484K 0.01% 1006
2020
Q3
$847K Buy
+4,636
New +$873K 0.02% 778
2020
Q1
Sell
-6,447
Closed -$1.21M 884
2019
Q4
$1.21M Sell
6,447
-465
-7% -$80K 0.05% 493
2019
Q3
$1.1M Buy
6,912
+306
+5% +$60.9K 0.02% 780
2019
Q2
$1.66M Buy
+6,606
New +$1.53M 0.04% 570
2018
Q4
Sell
-6,001
Closed -$1.7M 780
2018
Q3
$1.7M Buy
6,001
+1,180
+24% +$346K 0.06% 400
2018
Q2
$1.42M Buy
4,821
+614
+15% +$168K 0.06% 447
2018
Q1
$1.06M Buy
+4,207
New +$989K 0.06% 439
2017
Q4
Sell
-2,259
Closed -$420K 1235
2017
Q3
$420K Buy
+2,259
New +$394K 0.04% 760

Other funds holding ICUI

Pacer Advisors's ICUI Position: Q4 2023 in Review

Pacer Advisors sold out of ICU Medical (ICUI) in Q4 2023, closing a stake of 1,657 shares — an estimated $197K sold.

Pacer Advisors first reported a position in ICUI in Q3 2017 and held it in 16 quarters. The position peaked at $1.7M in Q3 2018. 241 funds tracked by Wall St. Rank hold ICUI as of Q4 2023.

  • Pacer Advisors reported no remaining ICU Medical position as of Q4 2023 after selling out during the quarter.
  • Pacer Advisors sold 1,657 ICU Medical shares in Q4 2023, an estimated $197K.
  • Pacer Advisors first reported a position in ICU Medical in Q3 2017 and held it in 16 quarters.
  • Pacer Advisors's ICU Medical position peaked at $1.7M in Q3 2018.
  • 241 funds tracked by Wall St. Rank held ICU Medical as of Q4 2023.

Based on Pacer Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.